Reduced striatal dopamine synthesis capacity is associated with symptoms of depression in patients with de novo unmedicated Parkinson's disease

Journal of Parkinson's Disease

Volumn 3, Issue 3, 2013, Pages 325-329

  Joutsa, Juho ^a   Rinne, Juha O ^a   Eskola, Olli ^a   Kaasinen, Valtteri ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Depression; Dopamine; FDOPA; Parkinson's disease; PET

Indexed keywords

6 FLUORODOPA F 18; DOPAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPAMINERGIC ACTIVITY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYMPTOM;

AGED; ANTIPARKINSON AGENTS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOSTRIATUM; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, PRESYNAPTIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84887856182     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-130205     Document Type: Article

References (16)

1. Gallagher DA, & Schrag A (2012) Psychosis, apathy, depression and anxiety in Parkinson's disease. Neurobiol Dis, 46, 581-589
2. Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, Duda JE, Stern MB,MozleyD,&Katz IR (2005) Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease J Nucl Med, 46, 227-232
3. Hesse S, Meyer PM, Strecker K, Barthel H, Wegner F, Oehlwein C, Isaias IU, Schwarz J, & Sabri O (2009) Monoamine transporter availability in Parkinson's disease patients with or without depression. Eur J Nucl Med Mol Imaging, 36, 428-435
4. Rektorova I, Srovnalova H, Kubikova R, & Prasek J (2008) Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease. Mov Disord, 23, 1580-1587
5. Di Giuda D, Camardese G, Bentivoglio AR, Cocciolillo F, Guidubaldi A, Pucci L, Bruno I, Janiri L, Giordano A, & Fasano A (2012) Dopaminergic dysfunction and psychiatric symptoms in movement disorders: A 123I-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging, 39, 1937-1948
6. Felicio AC, Moriyama TS, Godeiro-Junior C, Shih MC, Hoexter MQ, Borges V, Silva SM, Amaro-Junior E, Andrade LA, Ferraz HB,&BressanR A (2010) Higher dopamine transporter density in Parkinson's disease patients with depression. Psychopharmacology (Berl), 211, 27-31
7. Ceravolo R, Frosini D, Poletti M, Kiferle L, Pagni C, Mazzucchi S, Volterrani D, & Bonucelli U (2013) Mild affective symptoms in de novo Parkinson's disease patients: Relationship with dopaminergic dysfunction. Eur J Neurol, 20, 480-485
8. Broussolle E, Dentresangle C, Landais P, Garcia-Larrea L, Pollak P, Croisile B, Hibert O, Bonnefoi F, Galy G, Froment JC, & Comar D (1999) The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease. J Neurol Sci, 166, 141-151
9. Koerts J, Leenders KL, Koning M, Portman AT, & van Beilen M(2007) Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease. Eur J Neurosci, 25, 3132-3136
10. Kaasinen V, Nurmi E, Bergman J, Eskola O, Solin O, Sonninen P, & Rinne JO (2001) Personality traits and brain dopaminergic function in Parkinson's disease. Proc Natl Acad Sci U S A, 98, 13272-13277
11. Joutsa J, Martikainen K, Niemelä S, Johansson J, Forsback S, Rinne JO, & Kaasinen V (2012) Increased medial orbitofrontal [18F] fluorodopa uptake in Parkinsonian impulse control disorders. Mov Disord, 27, 778-782
12. Schrag A, Barone P, Brown RG, Leentjens AF, McDonald WM,Starkstein S,Weintraub D, PoeweW, Rascol O, Sampaio C, Stebbins GT, & Goetz CG (2007) Depression rating scales in Parkinson's disease: Critique and recommendations. Mov Disord, 22, 1077-1092
13. Mai JK, Paxinos G, Voss T (1997) Atlas of the Human Brain, Academic Press, San Diego
14. Patlak CS, & Blasberg RG (1985) Graphical evaluation of blood-To-brain transfer constants from multiple-Time uptake data. Generalizations. J Cereb Blood Flow Metab, 5, 584-590
15. Cubo E, Martin PM, Martin-Gonzalez JA, Rodriguez-Blazquez C, & Kulisevsky J (2010) Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease. Mov Disord, 25, 70-75
16. Global Parkinson's Disease Survey Steering, Committee (2002) Factors impacting on quality of life in Parkinson's disease: Results from an international survey. Mov Disord, 17, 60-67